Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OEQ Recall Period Assessment in Asthma with Symbicort or Budesonide
NCT00449527Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide in asthma, sponsored by AstraZeneca. Started Mar 2007; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00449527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449527.